Progress in Lung Cancer Screening Adoption

The National Lung Screening Trial, a landmark randomized clinical trial that demonstrated the efficacy of lung cancer screening with low-dose computed tomography (LDCT), was published more than a decade ago. In the interim, the US Preventive Services Task Force has endorsed lung cancer screening in certain adults, insurance coverage of LDCT has expanded, and a second large randomized clinical trial, the NELSON trial, demonstrated that LDCT can reduce lung cancer mortality. Importantly, annual LDCT screening also carries risks. In a recent observational study, approximately 32% of those screened underwent additional imaging, 3% had invasive testing, and 31% of those who received invasive testing had a complication.

Leggi
Agosto 2024